Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his ...

Robert F. Kennedy Jr. vows to finalize regulations for greater diverse patient involvement in clinical trials during his ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

The US Food and Drug Administration (FDA) recently issued a notice of noncompliance to the FADOI Foundation, citing the ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

"Poor representation in clinical trials reduces our understanding ... It was still accessible on the U.S. government's regulation.gov website. The FDA declined to comment, citing a pause on ...

Although it remains uncertain whether PROMs will realize their potential, Hoffman and Podgurski offer these proposals as ...

While experts across the political spectrum are generally in favor of stricter regulations ... big changes at the FDA do not bode well for scientific advancement: “Research could be delayed ...

At NIH, Memoli heads the Laboratory of Infectious Disease (LID) Clinical Studies Unit (CSU), where much of the research has ...